Loading...
Please wait, while we are loading the content...
Similar Documents
Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery
| Content Provider | MDPI |
|---|---|
| Author | Luo, Huilong Shusta, Eric V. |
| Copyright Year | 2020 |
| Description | The blood–brain barrier (BBB) is formed by brain microvascular endothelial cells that are sealed by tight junctions, making it a significant obstacle for most brain therapeutics. The poor BBB penetration of newly developed therapeutics has therefore played a major role in limiting their clinical success. A particularly challenging therapeutic target is glioma, which is the most frequently occurring malignant brain tumor. Thus, to enhance therapeutic uptake in tumors, researchers have been developing strategies to modulate BBB permeability. However, most conventional BBB opening strategies are difficult to apply in the clinical setting due to their broad, non-specific modulation of the BBB, which can result in damage to normal brain tissue. In this review, we have summarized strategies that could potentially be used to selectively and efficiently modulate the tumor BBB for more effective glioma treatment. |
| Starting Page | 1085 |
| e-ISSN | 19994923 |
| DOI | 10.3390/pharmaceutics12111085 |
| Journal | Pharmaceutics |
| Issue Number | 11 |
| Volume Number | 12 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2020-11-12 |
| Access Restriction | Open |
| Subject Keyword | Pharmaceutics Cell Tissue Engineering Blood–brain Barrier Drug Delivery Glioma Glioblastoma Targeting |
| Content Type | Text |
| Resource Type | Article |
